Cadrenal Therapeutics
CVKD
#10026
Rank
NZ$0.71 M
Marketcap
$0.67
Share price
-9.62%
Change (1 day)
-93.99%
Change (1 year)

Revenue for Cadrenal Therapeutics (CVKD)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cadrenal Therapeutics from 2023 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A